4
Changes in Ownership
Altimmune, Inc. Filed Acc 0001738048-20-000002
10% owner bought 1,303,636 shares at an average $8.74 ($11,395,493)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. 10% owner | 2020-05-26 | Purchase | +309,453 | $8.79 | $2,720,092 | 2,005,817 | I |
| Venrock Healthcare Capital Partners III, L.P. 10% owner | 2020-05-26 | Purchase | +390,547 | $9.78 | $3,819,550 | 2,396,364 | I |
| Venrock Healthcare Capital Partners III, L.P. 10% owner | 2020-05-27 | Purchase | +125,162 | $7.23 | $904,921 | 2,521,526 | I |
| Venrock Healthcare Capital Partners III, L.P. 10% owner | 2020-05-27 | Purchase | +277,000 | $7.92 | $2,193,840 | 2,798,526 | I |
| Venrock Healthcare Capital Partners III, L.P. 10% owner | 2020-05-28 | Purchase | +27,763 | $7.79 | $216,274 | 2,826,289 | I |
| Venrock Healthcare Capital Partners III, L.P. 10% owner | 2020-05-28 | Purchase | +173,711 | $8.87 | $1,540,817 | 3,000,000 | I |
| Open-market purchases · 1,303,636 sh · avg $8.74 · $11,395,493 | |||||||
Loading xslF345X03/edgar.xml…